Skip to main content
TipRanks
Go Ultimate75% OFF

IMPACT Therapeutics, Inc. Class H (7630) Income Statement

IMPACT Therapeutics, Inc. Class H Income Statement

Last quarter (Q2 2026), IMPACT Therapeutics, Inc. Class H's total revenue was $15.31M. In Q2, IMPACT Therapeutics, Inc. Class H's net income was $-13.22M. See IMPACT Therapeutics, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23
$ 5.33M$ 4.68M$ 33.27M
$ 4.49M$ 3.54M$ 32.14M
$ 36.53M$ 32.52M$ 36.14M
Depreciation and Amortization$ 623.31K$ 928.35K$ 1.14M
$ -31.42M$ -26.86M$ -1.60M
$ -32.04M$ -28.98M$ -4.00M
$ -9.19M$ -6.56M$ 1.18M
$ -41.23M$ -35.54M$ -2.82M
$ -41.23M$ -35.54M$ 519.73K
Per Share Metrics
Basic EPS$ -0.15$ -0.18$ 0.00
Diluted EPS$ -0.15$ -0.18$ 0.00
Weighted Average Shares Outstanding276.17M200.51M147.44M
Weighted Average Shares Outstanding (Diluted)276.17M200.51M147.44M

Currency in USD

IMPACT Therapeutics, Inc. Class H Earnings and Revenue History

-80M-40M040M-1000 %-500 %0 %500 %EarningsProfit Margin202320242025RevenueEarningsProfit Margin